Abramson JS, Siddiqi T, Garcia J, et al. Cytokine release syndrome and neurological event costs in lisocabtagene maraleucel-treated patients in the TRANSCEND NHL 001 trial. Blood Adv. 2021;5(6):1695-1705
Blood Adv. 2022 Nov 22;6(22):5885.
doi: 10.1182/bloodadvances.2021005392.